22 May 2013
Keywords: AstraZeneca, Emerging markets, Branded generics
Article | 17 March 2010
Anglo-Swedish drug major AstraZeneca is increasing its focus on the world’s emerging markets to sustain its growth over the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 March 2010
21 May 2013
© 2013 thepharmaletter.com